Hongda Xingye Past Earnings Performance
Past criteria checks 0/6
Hongda Xingye's earnings have been declining at an average annual rate of -25.1%, while the Chemicals industry saw earnings growing at 11.8% annually. Revenues have been declining at an average rate of 5.5% per year.
Key information
-25.1%
Earnings growth rate
-25.4%
EPS growth rate
| Chemicals Industry Growth | 12.1% |
| Revenue growth rate | -5.5% |
| Return on equity | -8.6% |
| Net Margin | -24.9% |
| Next Earnings Update | 29 Apr 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Hongda Xingye makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 23 | 3,212 | -801 | 772 | 113 |
| 30 Jun 23 | 4,189 | -455 | 572 | 125 |
| 31 Mar 23 | 4,747 | 199 | 491 | 123 |
| 31 Dec 22 | 4,822 | 300 | 475 | 115 |
| 30 Sep 22 | 4,690 | -191 | 178 | 176 |
| 30 Jun 22 | 5,578 | 339 | 228 | 182 |
| 31 Mar 22 | 5,791 | 685 | 233 | 170 |
| 01 Jan 22 | 6,523 | 852 | 243 | 179 |
| 30 Sep 21 | 7,129 | 1,560 | 313 | 167 |
| 30 Jun 21 | 6,303 | 1,273 | 259 | 158 |
| 31 Mar 21 | 5,593 | 892 | 202 | 159 |
| 31 Dec 20 | 5,394 | 814 | 232 | 156 |
| 30 Sep 20 | 5,171 | 727 | 165 | 119 |
| 30 Jun 20 | 5,072 | 687 | 208 | 112 |
| 31 Mar 20 | 5,336 | 631 | 337 | 118 |
| 31 Dec 19 | 5,300 | 630 | 333 | 104 |
| 30 Sep 19 | 5,779 | 433 | 592 | 134 |
| 30 Jun 19 | 5,954 | 466 | 636 | 124 |
| 31 Mar 19 | 6,037 | 549 | 657 | 111 |
| 31 Dec 18 | 6,045 | 611 | 657 | 111 |
| 30 Sep 18 | 6,042 | 813 | 722 | 17 |
| 30 Jun 18 | 6,404 | 920 | 671 | 24 |
| 31 Mar 18 | 6,458 | 953 | 692 | 18 |
| 31 Dec 17 | 6,541 | 1,005 | 687 | 18 |
| 30 Sep 17 | 7,384 | 1,153 | 636 | 4 |
| 30 Jun 17 | 6,994 | 1,047 | 602 | 0 |
| 31 Mar 17 | 6,372 | 1,014 | 527 | 0 |
| 31 Dec 16 | 6,158 | 818 | 508 | 0 |
| 30 Sep 16 | 4,870 | 743 | 433 | 0 |
| 30 Jun 16 | 4,570 | 631 | 355 | 0 |
| 31 Mar 16 | 4,585 | 591 | 357 | 0 |
| 31 Dec 15 | 4,087 | 559 | 347 | 0 |
| 30 Sep 15 | 3,949 | 428 | 273 | 0 |
| 30 Jun 15 | 3,825 | 427 | 276 | 0 |
| 31 Mar 15 | 3,536 | 361 | 217 | 0 |
| 31 Dec 14 | 3,320 | 347 | 196 | 0 |
| 30 Sep 14 | 2,875 | 360 | 178 | 0 |
| 30 Jun 14 | 2,505 | 311 | 171 | 0 |
| 31 Mar 14 | 2,481 | 330 | 145 | 0 |
| 31 Dec 13 | 2,417 | 296 | 142 | 0 |
| 30 Sep 13 | 2,349 | 303 | 89 | 0 |
| 30 Jun 13 | 2,310 | 265 | 82 | 0 |
| 31 Mar 13 | 2,044 | 188 | 80 | 0 |
Quality Earnings: 002002 is currently unprofitable.
Growing Profit Margin: 002002 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 002002 is unprofitable, and losses have increased over the past 5 years at a rate of 25.1% per year.
Accelerating Growth: Unable to compare 002002's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 002002 is unprofitable, making it difficult to compare its past year earnings growth to the Chemicals industry (-24.4%).
Return on Equity
High ROE: 002002 has a negative Return on Equity (-8.57%), as it is currently unprofitable.